Merck & Co., Inc. officer David M. Williams filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 21,359 shares of Merck common stock acquired through the exercise of options under a registered plan.
Natera, Inc. officer and director Steven Chapman filed a Form 144 notice on November 2, 2026, proposing the sale of 903 shares of Natera common stock through ETrade Corporation on NASDAQ.
Steven L. Chapman, an officer and director of Natera, Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 2,866 shares of Natera common stock on NASDAQ under Rule 144 of the Securities Act of 1933.
James Wassil, an officer of Vaxcyte, Inc., filed a Form 144 notice of proposed sale on November 2, 2026, indicating his intent to sell 2,250 shares of Vaxcyte common stock through UBS Financial Services, Inc. on NASDAQ.
Intellia Therapeutics, Inc. officer and director John M. Leonard filed a Form 144 notice on November 2, 2026, proposing to sell 9,000 shares of Intellia common stock through UBS Financial Services, Inc.
Walmart Inc. officer Daniel J. Bartlett filed a Form 144 notice of proposed sale on November 2, 2026, disclosing plans to sell 3,346 shares of Walmart common stock through broker Stephens Inc. under a Rule 10b5-1 trading plan adopted on March 12, 2026.
CB Financial Services, Inc. officer Jennifer L. George filed a Form 144 notice of proposed sale of 2,110 shares of common stock, dated November 2, 2026, with the sale to be executed through Stifel Nicolaus & Company Inc.
Laura Felice, an officer of BJ's Wholesale Club Inc, filed a Form 144 notice of proposed sale of 10,000 shares of common stock on November 2, 2026, under a Rule 10b5-1 trading plan adopted on September 2, 2025.
American Express Company officer Laureen E. Seeger filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 69,860 shares of common stock acquired through the exercise of options under a registered plan.
American Express Company officer Anna Marrs filed a Form 144 notice of proposed sale with the SEC on November 2, 2026, covering 44,910 shares of common stock acquired through the exercise of options under a registered plan.